Evidence map›Paper›PMID 31506907›Full record

ArticlePituitary2019

Prediction of recurrence and remission within 3 years in patients with Cushing disease after successful transnasal adenomectomy.

Elena Y Nadezhdina, Olga Yu Rebrova, Andrey Y Grigoriev, Oksana V Ivaschenko, Vilen N Azizyan, Galina A Melnichenko, Ivan I Dedov

Abstract read
PubMed Publisher
In one paragraph

Article in Pituitary, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Elena Y NadezhdinaEndocrinology Research Centre, 11 Dm. Ulyanova str., 117036, Moscow, Russia. e.yu.nadezhdina@gmail.com.ORCID http://orcid.org/0000-0002-9459-6428
Olga Yu RebrovaNational Research University Higher School of Economics, 20 Myasnitskaya Ul., 101000, Moscow, Russia.ORCID http://orcid.org/0000-0002-6733-0958
Andrey Y GrigorievEndocrinology Research Centre, 11 Dm. Ulyanova str., 117036, Moscow, Russia.ORCID http://orcid.org/0000-0002-9575-4520
Oksana V IvaschenkoEndocrinology Research Centre, 11 Dm. Ulyanova str., 117036, Moscow, Russia.ORCID http://orcid.org/0000-0002-6109-7550
Vilen N AzizyanEndocrinology Research Centre, 11 Dm. Ulyanova str., 117036, Moscow, Russia.ORCID http://orcid.org/0000-0001-9718-6099
Galina A MelnichenkoEndocrinology Research Centre, 11 Dm. Ulyanova str., 117036, Moscow, Russia.ORCID http://orcid.org/0000-0002-5634-7877
Ivan I DedovEndocrinology Research Centre, 11 Dm. Ulyanova str., 117036, Moscow, Russia.ORCID http://orcid.org/0000-0002-8175-7886
Endocrinology Research Center · RUNational Research University Higher School of Economics · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSome laboratory and clinical features are associated with a probability of recurrence after transnasal adenomectomy for Cushing disease (CD). However, there is no consensus on a set of predictors. Rules for prediction of recurrence were not proposed earlier.

aimTo develop prediction model of recurrence/remission after successful neurosurgical treatment for CD.

methodsRetrospective single-site comparative study included 349 patients (52 men and 297 women) with a verified diagnosis of CD who underwent effective endoscopic transsphenoidal adenomectomy between 2007 and 2014. Clinical and laboratory parameters were evaluated. Laboratory tests were performed using immunochemiluminescent method. Time-to-event analysis and ROC-analysis were applied. Multivariate models were developed using logistic regression and artificial neural network (ANN).

resultsPostoperative cortisol and ACTH levels and their combinations cannot be used for prediction of recurrence. ANN for prediction of recurrence within 3 years after successful surgery was developed. Input variables are age, duration of the disease, MRI data on adenoma, morning postoperative levels of ACTH and cortisol, output variable is binary (recurrence/remission). Predictive value for remission is 93%, 95% CI [89%; 96%], and predictive value for recurrence is 85%, 95% CI [71%; 94%]. Web-calculator based on the model is developed and free for use.

conclusionEffective method for prediction of recurrence and long-term remission within 3 years after successful endoscopic transsphenoidal adenomectomy is proposed.

Indexed as

AdolescentAdrenocorticotropic HormoneAdultAgedFemaleHumansHydrocortisoneMaleMiddle AgedMultivariate AnalysisNeoplasm Recurrence, LocalNeurosurgical ProceduresPituitary ACTH HypersecretionPituitary NeoplasmsRetrospective StudiesROC CurveAdrenocorticotropic HormoneHydrocortisoneCushing diseaseNeural networkNeuroendoscopyPituitary ACTH hypersecretionPredictionRecurrenceRemissionWeb calculator

Identifiers

PMID31506907
OpenAlexW2972564496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.